These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6815600)

  • 1. Promethazine hydrochloride therapy in severely Rh-sensitized pregnancies.
    Charles AG; Blumenthal LS
    Obstet Gynecol; 1982 Nov; 60(5):627-30. PubMed ID: 6815600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of erythroblastosis with promethazine hydrochloride.
    Gusdon JP
    J Reprod Med; 1981 Sep; 26(9):454-8. PubMed ID: 7288746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Promethazine in the treatment during pregnancy of severs forms of iso-immunization to Rhesus factor].
    Palliez R; Delecour M; Monnier JC; Begueri F; Leroy PY
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(2):199-201. PubMed ID: 4990805
    [No Abstract]   [Full Text] [Related]  

  • 4. Rhesus disease: the model for fetal therapy.
    Nicolaides KH; Rodeck CH
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh immunization in Manitoba: progress in prevention and management.
    Bowman JM; Pollock J
    Can Med Assoc J; 1983 Aug; 129(4):343-5. PubMed ID: 6409390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rh isoimmunization related to amniocentesis.
    Murray JC; Karp LE; Williamson RA; Cheng EY; Luthy DA
    Am J Med Genet; 1983 Dec; 16(4):527-34. PubMed ID: 6419606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal immunity to red cell antigens and fetal transfusion.
    Gibble JW; Ness PM
    Clin Lab Med; 1992 Sep; 12(3):553-76. PubMed ID: 1521427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial trials in the treatment of feto-maternal alloimmunization in the Rhesus system with oral administration of erythrocyte antigens].
    Parinaud J; Fournié A; Grandjean H; Blanc M; Pontonnier G
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(4):407-13. PubMed ID: 6415152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):563-5. PubMed ID: 6788016
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antenatal treatment of maternal-fetal Rh incompatibility hemolysis disease].
    Zhao L; Huang X; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jul; 33(7):406-8. PubMed ID: 10806699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylaxis of hemolytic disease of newborn].
    Kietlińska-Kmiolek Z
    Wiad Lek; 1971 Apr; 24(8):755-60. PubMed ID: 4996047
    [No Abstract]   [Full Text] [Related]  

  • 17. [Manifest feto-placental anasarca, treated in utero with success].
    Bierme R; Bierme S; Fournié R; Combel R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1967; 19(3):281. PubMed ID: 5586740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of central care of Rh-sensitized women for the prophylaxis of hemolytic disease of the newborn].
    Holtorff J; Brey J; Nitzsche M
    Zentralbl Gynakol; 1969 May; 91(20):629-47. PubMed ID: 4984542
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive agents in Rh immunization].
    Onnis A
    Attual Ostet Ginecol; 1969; 15(2):89-95. PubMed ID: 4998491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.